期刊文献+

细胞周期蛋白D1基因多态与人结直肠癌遗传易感性 被引量:4

Polymorphism of Cyclin D1 and Genetic Susceptibility to Colorectal Cancer of Human
下载PDF
导出
摘要 目的探讨细胞周期蛋白D1(Cyclin D1)基因第870位点单核苷酸多态(G870A)与结直肠癌(colorectal cancer,CRC)遗传易感性的关系。方法采用聚合酶链反应限制性片段长度多态性(PCR-RFLP)方法,检测345例CRC与670名对照的G870A基因型分布及差异。结果CRC和对照两组人群的Cyclin D1 G870A基因型分布差异无统计学意义(P>0.05)。与GG基因型相比,GA、AA基因型及A等位基因携带者(GA及AA基因型)的CRC风险分别为1.08倍(95%CI=0.75~1.54)、1.01倍(95%CI=0.68~1.51)及1.06倍(95%CI=0.75~1.49)。经性别、年龄、肿瘤位置、组织学分化程度和Dukes分期等因素分层分析,结果均显示G870A与CRC发病风险无显著性相关。结论Cyclin D1 G870A多态与宁波地区人群的CRC发病风险无相关性。 Objective To investigate the possible association between the G870A polymorphism of Cyclin D1 gene and susceptibility to colorectal cancer (CRC) in chinese population. Methods The Cyclin D1 G870A genotype was determined by PCR-based restriction fragment length polymorphism (RFLP) method in 345 CRC cases and 670 controls from Ningbo, Zhejiang province. Odds ratios (OR) for CRC and 95% confidence intervals (CI) from unconditional logistic regression models were used to evaluate relative risks. Potential risk factors were included in the logistic regression models as covariates in the multivariate analyses on genotype and CRC risk. Results No significant association between CRC risk and the G870A genotypes was found. Subjects with GA, AA and A-allele (GA and AA) genotypes had a similar 1.08- fold (95% CI = 0.75-1.54), 1.01-fold (95% CI = 0.68-1.51) and 1.06-fold (95% CI = 0.75-1.49) risk of CRC, respectively, when compared with those with GG genotype. Also, stratification analysis based on sex, age, tumor location, histological grade and Dukes stage did not reveal any significant association between CRC risk and the G870A polymorphism. Conclusion The Cyclin D1 G870A polymorphism may be not associated with CRC risk in this population.
出处 《解剖科学进展》 CAS 2008年第4期357-360,共4页 Progress of Anatomical Sciences
基金 国家自然科学基金资助项目(No.30470791) 南京军区医学科学技术研究"十一五"计划资助项目(06MA27)
关键词 结肠直肠肿瘤 基因 Cyclin D1 基因多态 遗传易感性 colorectal cancer gene, Cyclin D1 genetic polymorphism genetic susceptibility human
  • 相关文献

参考文献11

  • 1Bahnassy AA, Zekri AR, El-Houssini S, et al.Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients[J]. BMC Gastroenterol, 2004, 4:22.
  • 2Knudsen KE, Diehl JA, Haiman CA, et al.Cyclin D1: polymorphism, aberrant splicing and cancer risk[J]. Oncogene, 2006, 25(11): 1620- 1628.
  • 3Tan XL, Nieters A, Kropp S, et al. The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis[J]. Int J Cancer, 2008, 122(11):2573-2580.
  • 4Huang WS, Tang R, Lin PY, et al. Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan[J]. Dis Colon Rectum, 2006, 49(5):602-608.
  • 5Schernhammer ES, Tranah GJ, Giovannucci E, et al. Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma[J]. Br J Cancer, 2006, 94(6):928-934.
  • 6Kong S, Wei Q, Amos CI, et al. Cyclin D1 polymorphism and increased risk of colorectal cancer at young age[J]. J Natl Cancer Inst, 2001, 93(14): 1106-1108.
  • 7Hong Y, Eu KW, Seow-Choen F, et al. GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore[J]. Eur J Cancer, 2005, 41(7):1037-1044.
  • 8Le Marchand L, Seifried A, Lum-Jones A, et al. Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer[J]. JAMA, 2003, 290(21): 2843-2848.
  • 9Yoshiya G, Takahata T, Hanada N, et al. Influence of cancer-related gene polymorphisms on clinicopathological features in colorectal cancer[J]. J Gastroenterol Hepatol, 2008, 23(6): 948-953.
  • 10Zhang W, Gordon M, Press OA, et al. Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab[J]. Pharmacogenet Genomics, 2006, 16(7): 475-483.

同被引文献59

  • 1Hosokawa Y,Tu T,Tahara H,etal.Absence of cyclin D1/PRAD1 point mutations in human breast cancers and parathyroid adenomas and identification of a new cyclin D1 gene polymorphism[J].Cancer Lett,1995,93(2):165-70.
  • 2Josifovski T,Matevska N,Hiljadnikova-Bajro M,etal.Cyclin D1G870A variant is associated with increased risk of microsatellite instability-positive colorectal cancer in young male patients[J].BJMG,2007,10(2):29-36.
  • 3Forones N M,Lima JMd,Souza LG d,etal.Cyclin D1G870A polymorphism in Brazilian Colorectal Cancer Patients[J].J Gastrointest Canc,2008,39(1-4):118-23.
  • 4Grunhage F,Jungck M,Lamberti C,etal.Association of familial colorectal cancer with variants in the E-cadherin (CDH1)and cyclin D1(CCND1) genes[J].Int J Colorectal Dis,2008,23(2):147-54.
  • 5Talseth BA,Ashton KA,Meldrum C,etal.Aurora-A and Cyclin D1polymorphisms and the age of onset of colorectal cancer inhereditary nonpolyposis colorectal cancer[J].Int J Cancer,2008,122(6):1273-7.
  • 6Tan XL,Nieters A,Kropp S,etal.The association of cyclin D1G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis[J].Int J Cancer,2008,22(11):2573-80.
  • 7Liu B,Zhang YJ,Jin MJ,etal.Association of selected polymorphisms of CCND1,p21 and caspase8 with colorectal cancer risk[J].Mol Carcinog,2010,49(1):75-84.
  • 8Jain M,Kumar S,Lal P,Tiwari A,Ghoshal UC,Mittal B.Role of BCL2(ala43thr),CCND1(G870A)and FAS(A-670G) polymorphisms in modulating the risk of developing esophageal cancer[J].Cancer Detect Prev,2007,31(3):225-32.
  • 9Tahara T,Shibata T,Yamashi H,etal.Effect of cyclin D1 (CCND1) polymorphism on gastric premalignant condition[J].Clin Chem Lab Med,2008,46(12):1696-701.
  • 10Tahara T,Shibata T,Yamashi H,etal.Association between cyclin D1(CCND1) polymorphism and gastric cancer risk in Japanese population[J].Hepatogastroenterology,2009,56(93):1232-5.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部